Cargando…

Outcomes of sustained low efficiency dialysis versus continuous renal replacement therapy in critically ill adults with acute kidney injury: a cohort study

BACKGROUND: Sustained low efficiency dialysis (SLED) is increasingly used as a renal replacement modality in critically ill patients with acute kidney injury (AKI) and hemodynamic instability. SLED may reduce the hemodynamic perturbations of intermittent hemodialysis, while obviating the resource de...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitchlu, Abhijat, Adhikari, Neill, Burns, Karen E. A., Friedrich, Jan O., Garg, Amit X., Klein, David, Richardson, Robert M., Wald, Ron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522955/
https://www.ncbi.nlm.nih.gov/pubmed/26238520
http://dx.doi.org/10.1186/s12882-015-0123-4
_version_ 1782384015157755904
author Kitchlu, Abhijat
Adhikari, Neill
Burns, Karen E. A.
Friedrich, Jan O.
Garg, Amit X.
Klein, David
Richardson, Robert M.
Wald, Ron
author_facet Kitchlu, Abhijat
Adhikari, Neill
Burns, Karen E. A.
Friedrich, Jan O.
Garg, Amit X.
Klein, David
Richardson, Robert M.
Wald, Ron
author_sort Kitchlu, Abhijat
collection PubMed
description BACKGROUND: Sustained low efficiency dialysis (SLED) is increasingly used as a renal replacement modality in critically ill patients with acute kidney injury (AKI) and hemodynamic instability. SLED may reduce the hemodynamic perturbations of intermittent hemodialysis, while obviating the resource demands of CRRT. Although SLED is being increasingly used, few studies have evaluated its impact on clinical outcomes. METHODS: We conducted a cohort study comparing SLED (target 8 h/session, blood flow 200 mL/min, predominantly without anticoagulation) to CRRT in four ICUs at an academic medical centre. The primary outcome was mortality 30 days after RRT initiation, adjusted for demographics, comorbidity, baseline kidney function, and Sequential Organ Failure Assessment score. Secondary outcomes were persistent RRT dependence at 30 days and early clinical deterioration, defined as a rise in SOFA score or death 48 h after starting RRT. RESULTS: We identified 158 patients who initiated treatment with CRRT and 74 with SLED. Mortality at 30 days was 54 % and 61 % among SLED- and CRRT-treated patients, respectively [adjusted odds ratio (OR) 1.07, 95 % CI 0.56–2.03, as compared with CRRT]. Among SLED recipients, the risk of RRT dependence at 30 days (adjusted OR 1.36, 95 % CI 0.51–3.57) and early clinical deterioration (adjusted OR 0.73, 95 % CI 0.40–1.34) were not different as compared to patients who initiated CRRT. CONCLUSIONS: Notwithstanding the limitations of this small non-randomized study, we found similar clinical outcomes for patients treated with SLED and CRRT. While we await the completion of a trial that will definitively assess the non-inferiority of SLED as compared to CRRT, SLED appears to be an acceptable alternative form of renal support in hemodynamically unstable patients with AKI. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12882-015-0123-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4522955
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45229552015-08-04 Outcomes of sustained low efficiency dialysis versus continuous renal replacement therapy in critically ill adults with acute kidney injury: a cohort study Kitchlu, Abhijat Adhikari, Neill Burns, Karen E. A. Friedrich, Jan O. Garg, Amit X. Klein, David Richardson, Robert M. Wald, Ron BMC Nephrol Research Article BACKGROUND: Sustained low efficiency dialysis (SLED) is increasingly used as a renal replacement modality in critically ill patients with acute kidney injury (AKI) and hemodynamic instability. SLED may reduce the hemodynamic perturbations of intermittent hemodialysis, while obviating the resource demands of CRRT. Although SLED is being increasingly used, few studies have evaluated its impact on clinical outcomes. METHODS: We conducted a cohort study comparing SLED (target 8 h/session, blood flow 200 mL/min, predominantly without anticoagulation) to CRRT in four ICUs at an academic medical centre. The primary outcome was mortality 30 days after RRT initiation, adjusted for demographics, comorbidity, baseline kidney function, and Sequential Organ Failure Assessment score. Secondary outcomes were persistent RRT dependence at 30 days and early clinical deterioration, defined as a rise in SOFA score or death 48 h after starting RRT. RESULTS: We identified 158 patients who initiated treatment with CRRT and 74 with SLED. Mortality at 30 days was 54 % and 61 % among SLED- and CRRT-treated patients, respectively [adjusted odds ratio (OR) 1.07, 95 % CI 0.56–2.03, as compared with CRRT]. Among SLED recipients, the risk of RRT dependence at 30 days (adjusted OR 1.36, 95 % CI 0.51–3.57) and early clinical deterioration (adjusted OR 0.73, 95 % CI 0.40–1.34) were not different as compared to patients who initiated CRRT. CONCLUSIONS: Notwithstanding the limitations of this small non-randomized study, we found similar clinical outcomes for patients treated with SLED and CRRT. While we await the completion of a trial that will definitively assess the non-inferiority of SLED as compared to CRRT, SLED appears to be an acceptable alternative form of renal support in hemodynamically unstable patients with AKI. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12882-015-0123-4) contains supplementary material, which is available to authorized users. BioMed Central 2015-08-04 /pmc/articles/PMC4522955/ /pubmed/26238520 http://dx.doi.org/10.1186/s12882-015-0123-4 Text en © Kitchlu et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Kitchlu, Abhijat
Adhikari, Neill
Burns, Karen E. A.
Friedrich, Jan O.
Garg, Amit X.
Klein, David
Richardson, Robert M.
Wald, Ron
Outcomes of sustained low efficiency dialysis versus continuous renal replacement therapy in critically ill adults with acute kidney injury: a cohort study
title Outcomes of sustained low efficiency dialysis versus continuous renal replacement therapy in critically ill adults with acute kidney injury: a cohort study
title_full Outcomes of sustained low efficiency dialysis versus continuous renal replacement therapy in critically ill adults with acute kidney injury: a cohort study
title_fullStr Outcomes of sustained low efficiency dialysis versus continuous renal replacement therapy in critically ill adults with acute kidney injury: a cohort study
title_full_unstemmed Outcomes of sustained low efficiency dialysis versus continuous renal replacement therapy in critically ill adults with acute kidney injury: a cohort study
title_short Outcomes of sustained low efficiency dialysis versus continuous renal replacement therapy in critically ill adults with acute kidney injury: a cohort study
title_sort outcomes of sustained low efficiency dialysis versus continuous renal replacement therapy in critically ill adults with acute kidney injury: a cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522955/
https://www.ncbi.nlm.nih.gov/pubmed/26238520
http://dx.doi.org/10.1186/s12882-015-0123-4
work_keys_str_mv AT kitchluabhijat outcomesofsustainedlowefficiencydialysisversuscontinuousrenalreplacementtherapyincriticallyilladultswithacutekidneyinjuryacohortstudy
AT adhikarineill outcomesofsustainedlowefficiencydialysisversuscontinuousrenalreplacementtherapyincriticallyilladultswithacutekidneyinjuryacohortstudy
AT burnskarenea outcomesofsustainedlowefficiencydialysisversuscontinuousrenalreplacementtherapyincriticallyilladultswithacutekidneyinjuryacohortstudy
AT friedrichjano outcomesofsustainedlowefficiencydialysisversuscontinuousrenalreplacementtherapyincriticallyilladultswithacutekidneyinjuryacohortstudy
AT gargamitx outcomesofsustainedlowefficiencydialysisversuscontinuousrenalreplacementtherapyincriticallyilladultswithacutekidneyinjuryacohortstudy
AT kleindavid outcomesofsustainedlowefficiencydialysisversuscontinuousrenalreplacementtherapyincriticallyilladultswithacutekidneyinjuryacohortstudy
AT richardsonrobertm outcomesofsustainedlowefficiencydialysisversuscontinuousrenalreplacementtherapyincriticallyilladultswithacutekidneyinjuryacohortstudy
AT waldron outcomesofsustainedlowefficiencydialysisversuscontinuousrenalreplacementtherapyincriticallyilladultswithacutekidneyinjuryacohortstudy